Painreform (PRFX) Peer Comparison
$0.96
$-0.03
(-2.60%)
As on 28-Aug-2026 16:00EDT
Market cap
$3 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Edit
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
3 | 475 | 171 | 104 | 4 |
Revenue ($ Mln) |
0 | 192 | 12 | -- | 1 |
Net Profit ($ Mln) |
-4.84 | 22.25 | -20.18 | -31.50 | -12.18 |
Net Margin (%) |
-- | 11.60 | -170.10 | -- | -- |
RoE (%) |
-93.33 | 8.26 | -50.91 | -385.07 | -196.55 |
Price to Earnings |
-- | 21.68 | -- | -- | 0.07 |
Price-To-Book |
0.36 | 1.76 | 4.77 | 19.23 | 0.91 |
Cashflow ($ Mln)
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-3.96 | 27.59 | -14.53 | -27.88 | -4.14 |
|
Cash Flow from Investing Activities
|
-0.98 | -10.65 | -19.54 | -- | -1.40 |
|
Cash from Financing Activities
|
3.82 | -19.86 | 29.62 | 25.37 | 8.59 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-92.74 | 7.33 | -53.14 | -219.95 | -190.22 |
|
ROE (%)
|
-93.33 | 7.64 | -63.86 | -366.29 | -196.55 |
|
ROA (%)
|
-58.56 | 5.38 | -29.90 | -143.79 | -135.56 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-28,458.82 | 11.19 | -140.80 | -- | -1,422.78 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 0.12 | -0.16 | -- | -0.34 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
66.84 | 39.66 | 20.99 | -17.73 | -93.81 |
|
EPS Growth (%)
|
0.97 | 0.23 | 0.34 | 0.57 | -6.54 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-0.09 | 21.55 | -9.91 | -2.62 | -0.01 |
|
Price / Book Value
|
0.05 | 1.62 | 5.43 | 8.14 | 0.02 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
1.13 | 9.46 | -8.93 | -2.49 | 0.34 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.04 | 0.19 | 0.25 | 0.09 |
|
Short term debt to equity ratio
|
0.00 | 0.01 | 0.01 | 0.20 | 0.09 |
|
Current Ratio
|
1.78 | 4.07 | 2.33 | 1.97 | 2.41 |
|
Quick Ratio
|
-- | 2.28 | 2.17 | 1.82 | 2.38 |
|
Interest Coverage
|
-498.70 | 28.16 | -35.19 | -48.87 | -1,141.18 |
Operating Efficiency Ratios
| Painreform (PRFX) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Scisparc (SPRC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
835.29 | 16.10 | 13.99 | -- | 77.34 |
|
Asset Turnover
|
0.00 | 0.48 | 0.21 | 0.00 | 0.10 |
|
Receivable days
|
2,803.83 | 52.87 | 88.56 | -- | 1,200.08 |
|
Inventory Days
|
-- | 287.45 | 90.41 | -- | 152.59 |
|
Payable days
|
110.14 | 89.48 | 102.65 | -- | 1,297.86 |
|
Cash Conversion Cycle
|
-- | 250.84 | 76.33 | -- | 54.81 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
